| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* To whom correspondence should be addressed. E-mail: ake.lundwall{at}med.lu.se.
Beta-microseminoprotein (MSP) is one of the most abundant proteins secreted by the prostate gland. Since MSP is also synthesized in non-reproductive organs, the establishment of a solid relationship between the levels of MSP in serum and semen is crucial for future studies connecting MSP with aging or diseases of the prostate gland. We developed a specific, competitive, europium based immunoassay to measure MSP in serum and seminal plasma. We also produced recombinant MSP in insect cells using baculo virus and purified it to homogeneity by a novel approach using ethanol extraction and gel-filtration. The median values of MSP in 205 young men were 12 µg/L (2.5th-97.5th percentile, 4.9-26 µg/L) in serum and 0.53 g/L (2.5th-97.5th percentile, 0.13-2.0 g/L) or 1.8 mg (2.5th-97.5th percentile, 0.32-6.6 mg) in seminal plasma. MSP in serum showed significant correlation to MSP in seminal plasma (r = 0.50, P < 0.001). Significant correlations were also found in seminal plasma between MSP and PSA (r = 0.65, P < 0.001), and between MSP and Zn2+ (r = 0.54, P < 0.001). The yield of recombinant MSP in culure medium was 35 mg/L or higher, and the recovery following ethanol extraction was 80-90%. In conclusion, MSP in serum reflects the prostate secretion of MSP, and correlations were also found in seminal plasma between MSP and PSA and Zn2+. This suggests that MSP in serum can be used as a marker of prostate secretion, despite the contribution from extra prostatic tissues.
Key words: Prostate
Semen
Expression
Immunoassay
Purification
Serum
This article has been cited by other articles:
![]() |
K. M. Waters, D. O. Stram, L. Le Marchand, R. J. Klein, C. Valtonen-Andre, M. T. Peltola, L. N. Kolonel, B. E. Henderson, H. Lilja, and C. A. Haiman A Common Prostate Cancer Risk Variant 5' of Microseminoprotein-{beta} (MSMB) Is a Strong Predictor of Circulating {beta}-Microseminoprotein (MSP) Levels in Multiple Populations Cancer Epidemiol. Biomarkers Prev., October 1, 2010; 19(10): 2639 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, C. Valtonen-Andre, C. Savblom, C. Hallden, H. Lilja, and R. J. Klein Polymorphisms at the Microseminoprotein-{beta} Locus Associated with Physiologic Variation in {beta}-Microseminoprotein and Prostate-Specific Antigen Levels Cancer Epidemiol. Biomarkers Prev., August 1, 2010; 19(8): 2035 - 2042. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |